Technology
Nightingale’s internationally recognized biomarker analysis technology utilizes NMR (nuclear magnetic resonance) and an in-house developed quantification software to study and predict chronic diseases.
The leading approach to assess metabolic health
Our NMR-based technology provides a fine-grained snapshot of systemic metabolism and disease effects, measuring biomarkers from multiple pathways from one sample, in a single experiment.
High-throughput
Fast analysis even for the largest sample collections.
Low cost
Large coverage of biomarkers for an affordable price.
Consistent results
Sample preparation is minimal, resulting in comparable results between batches.
Accurate and precise
NMR-technology, our standard operating procedures and QMS all contribute to ensuring precise, repeatable and reproducible results.
Quality indicators
The intrinsic quality biomarkers in our blood panel can be identified to reveal samples of compromised quality.
Fully quantitative data
Biomarker measures provided in an easy-to-interpret format, in absolute concentrations (mmol/l, g/l and biologically meaningful ratios).
From research to clinics
Being used to analyse samples for leading research initiatives and healthcare settings, our technology is narrowing the gap between science and clinical use.
Partnerships
How it works
Nightingale’s technology is both affordable and scalable, accommodating any number of samples and providing fast delivery times. The platform handles every step of the process, from blood sample analysis to health data delivery.
Step 1
Each sample is tagged for identification.
Step 2
Minimal sample preparation, only buffer added.
Step 3
The NMR instrument scans the samples in a non-destructive way.
Step 4
NMR data is transformed into biomarkers of absolute concentrations.
Step 5
Results ready for analysis and interpretation.
Technology reviews
Ensuring quality data
Nightingale is committed to achieving high quality in all its services. Quality and compliance with all applicable regulatory and customer requirements underline all our operations.
Certified quality management system
Nightingale Health operates under a certified quality management system in accordance with EN ISO 13485:2016 (certified by Dekra).
Certified quality management system
Nightingale Health operates under a certified quality management system in accordance with EN ISO 13485:2016 (certified by Dekra).
CE-marked technology
Nightingale measures all samples with a CE-marked IVD device.
CE-marked technology
Nightingale measures all samples with a CE-marked IVD device.
External Quality Assurance
Nightingale Health participates in UK NEQAS and WEQAS programs to monitor its measurement quality between Nightingale and other laboratories.
External Quality Assurance
Nightingale Health participates in UK NEQAS and WEQAS programs to monitor its measurement quality between Nightingale and other laboratories.
Healthcare quality
Procedures for clinical laboratory tests are in accordance with standard for medical laboratories (EN ISO 15189). Products intended for clinical use offered by Nightingale are calibrated to standard materials provided by National Institute of Standards and Technology (NIST). Method validation is done according to CLIA’s US FDA recognised consensus standards. Validated biomarkers: creatinine, glucose, cholesterol, HDL-C, LDL-C, triglycerides, ApoA1 and ApoB.
Healthcare quality
Procedures for clinical laboratory tests are in accordance with standard for medical laboratories (EN ISO 15189). Products intended for clinical use offered by Nightingale are calibrated to standard materials provided by National Institute of Standards and Technology (NIST). Method validation is done according to CLIA’s US FDA recognised consensus standards. Validated biomarkers: creatinine, glucose, cholesterol, HDL-C, LDL-C, triglycerides, ApoA1 and ApoB.
Contact
Whether you have a question or you would like to ask for an offer, let us know and we'll get back to you very soon.
